N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
In Re ENTRESTO (SACUBITRIL/VALSARTAN)
-------------------------------------------------
NOVARTIS PHARMACEUTICALS CORPORATION,
Plaintiff-Appellant
v.
TORRENT PHARMA INC., TORRENT
PHARMACEUTICALS LTD.
Defendants-Appellees
-------------------------------------------------
NOVARTIS PHARMACEUTICALS CORPORATION,
Plaintiff-Appellant
v.
ALEMBIC PHARMACEUTICALS LIMITED,
ALEMBIC PHARMACEUTICALS INC.,
Defendants
-------------------------------------------------
NOVARTIS PHARMACEUTICALS CORPORATION,
Plaintiff-Appellant
v.
Case: 23-2218 Document: 53 Page: 1 Filed: 03/06/2024
-- 1 of 3 --
IN RE ENTRESTO ( SACUBITRIL/ VALSARTAN) 2
HETERO USA, INC., HETERO LABS LIMITED,
HETERO LABS LIMITED UNIT-III, MSN
PHARMACEUTICALS, INC., MSN LABORATORIES
PRIVATE LTD., MSN LIFE SCIENCES PRIVATE
LTD.,
Defendants-Appellees
______________________
2023-2218, 2023-2219, 2023-2220, 2023-2221
______________________
Appeals from the United States District Court for the
District of Delaware in Nos. 1:19-cv-01979-RGA, 1:19-cv-
02021-RGA, 1:19-cv-02053-RGA, and 1:20-md-02930-RGA,
Judge Richard G. Andrews.
-------------------------------------------------
NOVARTIS PHARMACEUTICALS CORPORATION,
Plaintiff-Appellant
v.
MYLAN PHARMACEUTICALS INC.,
Defendant-Appellee
______________________
2023-2260
______________________
Appeal from the United States District Court for the
Northern District of West Virginia in No. 1:19-cv-00201-
TSK, Chief Judge Thomas S. Kleeh.
______________________
O R D E R
Novartis Pharmaceuticals Corporation and Mylan
Pharmaceuticals Inc. submit a joint stipulation to dismiss
Case: 23-2218 Document: 53 Page: 2 Filed: 03/06/2024
-- 2 of 3 --
IN RE ENTRESTO ( SACUBITRIL/ VALSARTAN) 3
Appeal No. 2023-2260 pursuant to Rule 42(b)(1) of the Fed-
eral Rules of Appellate Procedure, agreeing that each bear
its own costs with respect to Appeal No. 2023-2260.
Upon consideration thereof,
I T I S O RDERED T HAT :
(1) Appeal No. 2023-2260 is deconsolidated from Ap-
peal Nos. 2023-2218, 2023-2219, 2023-2220, and 2023-
2221, and Appeal No. 2023-2260 is dismissed. Each side
shall bear its own costs regarding Appeal No. 2023-2260.
(2) The stay in Appeal Nos. 2023-2218, 2023-2219,
2023-2220, and 2023-2221 is lifted.
(3) The Clerk of Court shall transmit a copy of this or-
der to the merits panel assigned to Appeal Nos. 2023-2218,
2023-2219, 2023-2220, and 2023-2221.
March 6, 2024
Date
F OR THE COURT
ISSUED AS A MANDATE (as to Appeal No. 2023-2260
only): March 6, 2024
Case: 23-2218 Document: 53 Page: 3 Filed: 03/06/2024
-- 3 of 3 --